Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer : The Randomized Clinical FinXX Trial
Year of publication
2017
Authors
Joensuu, Heikki; Kellokumpu-Lehtinen, Pirkko-Liisa; Huovinen, Riikka; Jukkola-Vuorinen, Arja; Tanner, Minna; Kokko, Riitta; Ahlgren, Johan; Auvinen, Paivi; Lahdenpera, Outi; Kosonen, Sanna; Villman, Kenneth; Nyandoto, Paul; Nilsson, Greger; Poikonen-Saksela, Paula; Kataja, Vesa; Junnila, Jouni; Bono, Petri; Lindman, Henrik
Show moreOrganizations and authors
Helsinki University Hospital
Joensuu Heikki
Nyandoto Paul
Poikonen-Saksela Paula
Bono Petri
Kokko Riitta
Oulu University Hospital
Jukkola-Vuorinen Arja
Publication type
Publication format
Article
Report
No
Parent publication type
Journal
Article type
Original articleAudience
ScientificPeer-reviewed
Peer-ReviewedMINEDU's publication type classification code
A1 Journal article (refereed), original researchPublication channel information
Journal/Series
Parent publication name
Volume
3
Issue
6
Pages
793-800
ISSN
Publication forum
Publication forum level
1
Open access
Open access in the publisher’s service
Yes
Open access of publication channel
Partially open publication channel
Self-archived
No
Other information
Fields of science
Pharmacy; General medicine, internal medicine and other clinical medicine; Cancers
Identified topic
[object Object]
Internationality of the publisher
International
International co-publication
Yes
Co-publication with a company
Yes
DOI
10.1001/jamaoncol.2016.6120
The publication is included in the Ministry of Education and Culture’s Publication data collection
Yes